Literature DB >> 381698

A direct hepatotoxic effect of valproic acid.

N M Sussman, L W McLain.   

Abstract

Nine patients treated with valproic acid had low plasma fibrinogen concentration and other liver function abnormalities. Several patients also had a low platelet count and prolonged bleeding time. The abnormal values returned promptly to normal when the drug therapy was discontinued or the dosage reduced. The liver function abnormalities are consistent with a direct, dose-related hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381698

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Valproic acid-associated encephalopathy.

Authors:  G L Jones; F Matsuo; J R Baringer; W H Reichert
Journal:  West J Med       Date:  1990-08

Review 3.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

4.  Anti-epileptic therapy and fatal chickenpox.

Authors:  R V Williamson; B Ramsay; J Lee; J J Cream
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

5.  A case of valproate intoxication with excessive brain edema.

Authors:  G Hintze; H H Klein; H Prange; H Kreuzer
Journal:  Klin Wochenschr       Date:  1987-05-04

Review 6.  Felbamate in epilepsy therapy: evaluating the risks.

Authors:  J M Pellock
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 7.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

8.  Lack of effect of valproate on paracetamol (acetaminophen) disposition in epileptic patients.

Authors:  I M Kapetanović; H J Kupferberg; W Theodore; R J Porter
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 9.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 10.  Influence of co-medication on the metabolism of valproate.

Authors:  F Pisani
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.